BIIB
Biogen·NASDAQ
--
--(--)
--
--(--)
4.05 / 10
Netural
Technical evaluation scores 4.05/10, deemed neutral. No bullish signals appear; MACD Golden Cross, RSI Overbought, Marubozu White and MACD Death Cross all show modest or bearish bias. The market appears volatile with unclear direction.
Analysis Checks(0/4)
RSI Overbought
Score4.58/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.54%
Score4.58/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.54%
MACD Golden Cross
Score4.29/10
Win Rate53.85%
Hist. Signals13
Avg Return0.29%
Score4.29/10
Win Rate53.85%
Hist. Signals13
Avg Return0.29%
MACD Death Cross
Score4.62/10
Win Rate54.55%
Hist. Signals11
Avg Return0.61%
Score4.62/10
Win Rate54.55%
Hist. Signals11
Avg Return0.61%
Marubozu White
Score2.7/10
Win Rate42.86%
Hist. Signals7
Avg Return0.02%
Score2.7/10
Win Rate42.86%
Hist. Signals7
Avg Return0.02%
RSI Overbought
Score4.58/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.54%
Score4.58/10
Win Rate58.33%
Hist. Signals12
Avg Return-0.54%
MACD Death Cross
Score4.62/10
Win Rate54.55%
Hist. Signals11
Avg Return0.61%
Score4.62/10
Win Rate54.55%
Hist. Signals11
Avg Return0.61%
MACD Golden Cross
Score4.29/10
Win Rate53.85%
Hist. Signals13
Avg Return0.29%
Score4.29/10
Win Rate53.85%
Hist. Signals13
Avg Return0.29%
Marubozu White
Score2.7/10
Win Rate42.86%
Hist. Signals7
Avg Return0.02%
Score2.7/10
Win Rate42.86%
Hist. Signals7
Avg Return0.02%
What is the current technical signals for BIIB?
- BIIB presents a Netural setup with a Technical Score of 4.05/10. Key technical indicators highlight an RSI of 56.85 and a MACD of 0.57, with the trend anchored by the 50-Day SMA at 184.51. Traders should monitor key support at 186.27 and resistance at 190.74.
